Filters
Tumor Antigen Peptide (Customized)
Catalog peptides
Synthesis of unnatural amino acids and other blocks

Mazdutide

Name
Mazdutide
Molecular structural formula
CAS Number
2259884-03-0
Formula
C210H322N46O67
MW
4563.06
Sequence Shortening
HAEGTFTSDVSSYLEGQAA-{Lys-N6-[N-(1-oxohexadecyl)-L-g-glutamyl]}-EFIAWLVRGRG
Sequence
H-{Aib}-QGTFTSDYSKYLDEKKAK-{AEEA-AEEA-γGlu-Nonadecanoic acid}-EFVEWLLEGGPSSG-NH2
InChIKey
His-{Aib}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Lys-Lys-Ala-Lys-{AEEA-AEEA-γGlu-Nonadecanoic acid}-Glu-Phe-Val-Glu-Trp-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-NH2
Solubility in water
22.22 mg/mL
Purity
≥98%
References
[1]. Chen T, et al. The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial Diseases. J Med Chem. 2022 Mar 10;65(5):3685-3705. [2]. Jiang H, et al. A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetes. Nat Commun. 2022 Jun 24;13(1):3613. [3]. Chen Y, Mezo A, Coskun T, et al. 682-P: novel dual glucagon and glucagon-like peptide-1 receptor agonist LY3305677 improves glucose control, reduces body weight, and increases energy expenditure in mice[J]. Diabetes, 2021, 70(Supplement_1).
Target
GCGR, GLP Receptor
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Masudopeptide is the world's first approved glucagon/glucagon-like peptide-1 dual receptor agonist. It suppresses appetite and promotes insulin secretion by activating the GLP-1 receptor, while activating the GCG receptor to increase energy consumption and fat decomposition, especially significantly improving liver fat metabolism.